Mikheeva S, Jarrell K A
Department of Pharmacology and Experimental Therapeutics, Boston University Medical Center, MA 02118, USA.
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7486-90. doi: 10.1073/pnas.93.15.7486.
We report the use of engineered ribozymes to shuffle exon cassettes in vitro. Specifically, we have designed derivatives of a group II intron that insert into selected sites in the human tissue plasminogen activator (t-PA) mRNA. The insertion reaction links t-PA sequences to the group II intron sequences so that trans-splicing reactions catalyzed by the intron can be employed to shuffle the t-PA sequences. We expect these results to be generalizable, so that similar ribozymes can be designed to target any desired 13 nucleotide sequence. In principle, the reactions we describe here should be able to link any RNA molecule to any other RNA molecule at any selected point.
我们报道了利用工程化核酶在体外对外显子盒进行改组。具体而言,我们设计了II组内含子的衍生物,它们可插入人组织型纤溶酶原激活剂(t-PA)mRNA的选定位点。插入反应将t-PA序列与II组内含子序列连接起来,这样由内含子催化的反式剪接反应就可用于改组t-PA序列。我们期望这些结果具有普遍性,从而可以设计出类似的核酶来靶向任何所需的13个核苷酸序列。原则上,我们在此描述的反应应该能够在任何选定的位点将任何RNA分子与任何其他RNA分子连接起来。